Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Checkpoint Therapeutics, Inc.
Merck Sharp & Dohme LLC